October 21st 2024
A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Uterine Risk Factors Impact Endometrial Cancer Survival
April 4th 2011Uterine risk factors (RF) strongly influence survival of women with endometrial cancer, independent of nodal metastasis, according to research published in the March issue of the American Journal of Obstetrics & Gynecology.
Read More
Number of Cancer Survivors in U.S. Reaches 11.7 Million
March 29th 2011The number of cancer survivors in the United States had increased to nearly 12 million by 2007, according to a report in the March 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Read More
Coding of Ovarian Cancer Diagnosis Delayed
March 29th 2011Free text contains extra information relating to the diagnosis of ovarian cancer, and in some cases indicates a time lag between the diagnosis and coding in the medical record, according to a study published online Feb. 23 in BMJ Open.
Read More
Cancer Patients Willing to Undergo Pre-Trial Testing
March 26th 2011Patients with advanced malignancies appear to be quite willing to undergo pharmacodynamic (PD) and pharmacokinetic (PK) tests in order to be enrolled in clinical trials, according to research published online Jan. 18 in Cancer.
Read More
Is Medicare Dangerous to Your Patient’s Health? If They Have Ovarian Cancer, Yes
March 15th 2011According to government estimates, the incidence of ovarian cancer is almost 13 per 100,000 women per year, and most cases are diagnosed in an advanced stage. As such, proper treatment is critical to ensure survival. However, Dr Melissa M. Thrall, fellow in the department of obstetrics and gynecology at the University of Washington, found that less than 40% of women reliant on Medicare receive standard care.
Read More
Understanding Referral Patterns for Ovarian Cancer
March 14th 2011Primary care physicians are the entry point for care for many patients. They are often responsible for determining when additional expertise is needed and to which specialist a patient should go for additional care. Although studies have shown that gynecologic oncologists can improve surgical and survival outcomes for patients with ovarian cancer, the referral rate from primary care physicians to gynecologic oncologists remains relatively low.
Read More